Elekta announced that its Extend for Leksell Gamma Knife Perfexion has received 510(k) clearance from the FDA, and is now available in the United States.

Extend is a stereotactic treatment program that lets clinicians apply Gamma Knife surgery to a class of targets, including certain cancers of the head and neck, according to the Stockholm, Sweden-based company. With a re-locatable frame and support for fractionated treatments, Extend provides cross functions in both stereotactic radiosurgery and stereotactic radiation therapy for both neurosurgeons and radiation oncologists, Elekta said.